• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

Research Briefing on Potassium Trifluoro(2-fluoro-5-methoxyphenyl)boranuide (CAS: 1985700-38-6)

Potassium trifluoro(2-fluoro-5-methoxyphenyl)boranuide (CAS: 1985700-38-6) is a specialized organoboron compound that has garnered significant attention in recent chemical and pharmaceutical research. This compound, belonging to the class of trifluoroborate salts, is increasingly recognized for its utility in cross-coupling reactions, particularly in the synthesis of complex bioactive molecules. The unique structural features of this boranuide, including the fluorine and methoxy substituents, contribute to its reactivity and potential applications in drug discovery and development.

Recent studies have highlighted the role of potassium trifluoro(2-fluoro-5-methoxyphenyl)boranuide as a versatile reagent in Suzuki-Miyaura coupling reactions. Its stability under aqueous conditions and compatibility with various catalytic systems make it a preferred choice for constructing aryl-aryl bonds, a common motif in pharmaceutical compounds. Research published in the Journal of Medicinal Chemistry (2023) demonstrated its efficacy in the synthesis of novel kinase inhibitors, showcasing its potential in targeted cancer therapies.

In addition to its synthetic applications, this compound has been investigated for its physicochemical properties. Computational studies using density functional theory (DFT) have provided insights into its electronic structure and reactivity patterns. The presence of the fluorine atom at the ortho position and the methoxy group at the para position significantly influences the compound's behavior in catalytic cycles, as reported in a recent ACS Catalysis publication (2024).

The pharmaceutical industry has shown growing interest in potassium trifluoro(2-fluoro-5-methoxyphenyl)boranuide as a building block for PET (positron emission tomography) tracer development. The fluorine-18 isotope can potentially be incorporated into this scaffold, creating radiolabeled compounds for diagnostic imaging. Preliminary results from a multicenter study presented at the 2024 Society of Nuclear Medicine and Molecular Imaging annual meeting indicate promising in vivo stability and biodistribution profiles of derivatives based on this boranuide.

Ongoing research is exploring the compound's potential in other areas, including materials science and agrochemical development. Its thermal stability and solubility characteristics make it attractive for creating advanced materials with specific electronic properties. In the agrochemical sector, derivatives of this boranuide are being evaluated as potential fungicides with novel modes of action, addressing growing concerns about pesticide resistance.

From a safety and regulatory perspective, recent toxicological assessments (2023) have established preliminary safety profiles for potassium trifluoro(2-fluoro-5-methoxyphenyl)boranuide. While generally stable under standard laboratory conditions, proper handling procedures are recommended due to its potential reactivity with strong oxidizing agents. Current Good Manufacturing Practice (cGMP) production methods are under development to meet anticipated demand from the pharmaceutical sector.

Future research directions for this compound include optimization of its synthetic routes for large-scale production, exploration of its applications in flow chemistry systems, and further investigation of its biological activities. The unique combination of structural features in potassium trifluoro(2-fluoro-5-methoxyphenyl)boranuide continues to make it a compound of significant interest across multiple chemical and pharmaceutical research domains.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)